| Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
| Your comments are welcome:
submit feedback
|
|
| Disclosure reporting details |
|
Back to search detail summary
|
|
:
01/01/2024 - 06/30/2024
|
|
Authorizing Officer name
|
Joseph
A.
Boncore
|
|
Title
|
Principal
|
|
Business name
|
Commonwealth Counsel, LLC
|
|
Address
|
146 Bowdoin Street
Unit G-7
|
|
City, state, zip code
|
Boston, MA 02108
|
|
Country
|
US
|
|
Phone
|
617-429-2068
|
|
|
|
|
Client Compensation
|
| SUN Initiative Financing LLC |
$30,000.00
|
| Camp Harbor View Foundation, Inc. |
$60,000.00
|
| Flatiron Energy Development LLC |
$25,000.00
|
| Pharmaceutical Research and Manufacturers of America Corporation |
$30,000.00
|
| Keolis Commuter Services, LLC |
$45,000.00
|
| Friends of the Children - Boston |
$45,000.00
|
| Alexion Pharmaceuticals, Inc. |
$60,000.00
|
| Massachusetts Biotechnology Council, Inc. |
$90,000.00
|
| Neighborhood of Affordable Housing, Inc. |
$30,000.00
|
| Total salaries received |
$415,000.00
|
|
|
| |
|
Compensation/Salaries Paid
|
|
Joseph A. Boncore
|
$139,499.96
|
|
Shannon Moore
|
$55,961.53
|
| Total salaries paid |
$195,461.49
|
|
| |
|
Activities, Bill Numbers and Titles
|
| No activities, bill numbers or bill titles were disclosed for this reporting period. |
|
| |
|
Operating Expenses
|
| 06/30/2024 |
Adobe Systems
|
Advertising expenses
|
$84.96
|
| 06/30/2024 |
Boston Business Journal
|
Advertising expenses
|
$755.00
|
| 06/30/2024 |
Boston College
|
Professional dues
|
$2,500.00
|
| 06/30/2024 |
Gravoc Associates, Inc.
|
Other operating expenses
|
$495.00
|
| 06/30/2024 |
GoDaddy
|
Professional subscriptions
|
$158.97
|
| 06/30/2024 |
Golden Dome LLC
|
Rent
|
$22,703.23
|
| 06/30/2024 |
InstaTrac
|
Other operating expenses
|
$3,350.00
|
| 06/30/2024 |
Intuit Quickbooks
|
Professional subscriptions
|
$600.32
|
| 06/30/2024 |
LinkedIn
|
Advertising expenses
|
$637.44
|
| 06/30/2024 |
Massachusetts Bankers Association
|
Professional dues
|
$2,120.00
|
| 06/30/2024 |
Massachusetts Tax Payers Association
|
Professional dues
|
$1,200.00
|
| 06/30/2024 |
Northeast Clean Energy Council
|
Professional dues
|
$3,200.00
|
| 06/30/2024 |
Staples
|
Office supplies, equipment
|
$50.76
|
| 06/30/2024 |
RBN Design Marketing
|
Advertising expenses
|
$3,553.85
|
| 06/30/2024 |
Constant Contact
|
Advertising expenses
|
$690.67
|
| 06/30/2024 |
Comcast
|
Internet fees
|
$2,265.75
|
| 06/30/2024 |
Brick Marketing
|
Advertising expenses
|
$2,000.00
|
| | | Total operating expenses |
$46,365.95
|
|
| |
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
|
06/30/2024
|
06/30/2024
| Commonwealth Counsel, LLC |
Omni New Haven Hotel
|
Lodgings while attending event at Alexion Pharmaceuticals headquarters
|
$201.06
|
| | | | | Total amount |
$201.06
|
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
| |
|
Lobbyist: Joseph A. Boncore
|
|
Client:
Massachusetts Biotechnology Council, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
1055
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1247
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
714
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1418
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4804
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1131
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
744
|
An Act establishing medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2800
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1369
|
An Act to establish a pilot program for specialty pharmacy in urology
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4773
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
976
|
An Act requiring full health insurance coverage for individuals with vitiligo
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
656
|
An Act to reduce the cost of pharmacy benefits
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1356
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4722
|
An Act relative to strengthening Massachusetts' economic leadership
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1056
|
An Act establishing a commission to study maximum allowable costs lists
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1250
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
715
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1425
|
An Act relative to pharmacists as healthcare providers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
4
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
959
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1208
|
An Act establishing a state-wide drug repository program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
630
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1191
|
An Act relative to pay range disclosure
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4707
|
An Act relative to the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1016
|
An Act to enact pharmacy benefit manager duties
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1239
|
An Act establishing Medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1375
|
An Act relative to postpartum depression screening
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4789
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2163
|
An Act relative to postpartum depression screenings
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1862
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2484
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
850
|
An Act concerning the use of animals in product testing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4100
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
753
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2
|
Governor's Budget
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1206
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
616
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1181
|
An Act relative to transparency in the workplace
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4459
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1147
|
An Act ensuring access to specialty medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2249
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2499
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2834
|
An Act relative to the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1180
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4109
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
767
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
943
|
An Act to reduce co-pays for people with chronic conditions
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1197
|
An Act to provide rapid whole genome sequencing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
227
|
An Act establishing the Massachusetts Information Privacy and Security Act
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
2209
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
944
|
An Act reining in premiums through stronger rate review
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1202
|
An Act to preserve special needs trusts for disabled seniors
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
799
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4109
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1150
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3587
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
750
|
An Act relative to primary care for you
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
801
|
An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4138
|
An Act [sic] the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Joseph A. Boncore
|
|
Client:
Pharmaceutical Research and Manufacturers of America Corporation
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Center for Health Information and Analysis (CHIA)
|
prescribtion drug pricing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
959
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Office of the Governor
|
prescription drug pricing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1016
|
An Act to enact pharmacy benefit manager duties
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Joseph A. Boncore
|
|
Client:
Flatiron Energy Development LLC
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
3216
|
An Act relative to clean energy generation
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3166
|
An Act increasing opportunities for clean peak energy storage
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4503
|
An Act relative to clean energy generation
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3992
|
An Act to expand customer access to a modern grid
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2892
|
An Act upgrading the grid and protecting ratepayers
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3204
|
An Act establishing off-peak charging rebates
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2838
|
An Act upgrading the grid and protecting ratepayers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2531
|
An Act advancing grid enhancement technologies
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2140
|
An Act establishing off-peak charging rebates
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2531
|
An Act advancing grid enhancement technologies
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
4222
|
An Act advancing grid enhancement technology
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Joseph A. Boncore
|
|
Client:
SUN Initiative Financing LLC
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
1104
|
An Act relative to mortgage review boards and a small business loan review board within the Division of Banks
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1404
|
An Act relative to acute hospital governance
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Attorney General's Office (AGO)
|
Discussion regarding the Shared appreciation mortgages and potential regulations
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Joseph A. Boncore
|
|
Client:
Camp Harbor View Foundation, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Other
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
4
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4600
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2800
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4601
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Joseph A. Boncore
|
|
Client:
Keolis Commuter Services, LLC
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
2400
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3315
|
An Act improving rail service on the Fairmount commuter rail line
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2402
|
An Act improving rail service on the Fairmount commuter rail line
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3901
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3908
|
An Act improving rail service on the Fairmount commuter rail line
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2217
|
An Act relative to setting deadlines to electrify the MBTA commuter rail
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3392
|
An Act relative to setting deadlines to electrify the commuter rail
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Office of the Governor
|
Matters concerning commuter rail service in the Commonwealth. Expanded service, electrification of commuter rail and Battery Electric Mulitple unit trains /electric trains.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3366
|
An Act electrifying regional transit authorities
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2271
|
An Act improving rail service on the Fairmount commuter rail line
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Joseph A. Boncore
|
|
Client:
Friends of the Children - Boston
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Other
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Attorney General's Office (AGO)
|
Discussion regarding mentorship programing and grant making authority of Attorney General's Office
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2800
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4600
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
4
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Joseph A. Boncore
|
|
Client:
Neighborhood of Affordable Housing, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services)
|
Discussions with Secretariat of Housing and Livable Communities regarding affordable housing in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4726
|
Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2834
|
Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Joseph A. Boncore
|
|
Client:
Alexion Pharmaceuticals, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
801
|
An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
976
|
An Act requiring full health insurance coverage for individuals with vitiligo
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
656
|
An Act to reduce the cost of pharmacy benefits
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1356
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
943
|
An Act to reduce co-pays for people with chronic conditions
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1197
|
An Act to provide rapid whole genome sequencing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
227
|
An Act establishing the Massachusetts Information Privacy and Security Act
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1180
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4109
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
767
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1206
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
616
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1181
|
An Act relative to transparency in the workplace
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
850
|
An Act concerning the use of animals in product testing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4100
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
753
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
944
|
An Act reining in premiums through stronger rate review
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
799
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
959
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1208
|
An Act establishing a state-wide drug repository program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
630
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1191
|
An Act relative to pay range disclosure
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1055
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1247
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
714
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1418
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Office of the Governor
|
Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1150
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3587
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
750
|
An Act relative to primary care for you
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1369
|
An Act to establish a pilot program for specialty pharmacy in urology
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1056
|
An Act establishing a commission to study maximum allowable costs lists
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1250
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
715
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1425
|
An Act relative to pharmacists as healthcare providers
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2163
|
An Act relative to postpartum depression screenings
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1862
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1131
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
744
|
An Act establishing medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2492
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1016
|
An Act to enact pharmacy benefit manager duties
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1239
|
An Act establishing Medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1375
|
An Act relative to postpartum depression screening
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services)
|
Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1147
|
An Act ensuring access to specialty medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2249
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2499
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 01/29/2024 | Joseph A. Boncore |
Maura Healey Committee
|
Governor, Massachusetts
|
$200.00
|
| 01/31/2024 | Joseph A. Boncore |
Meghan Kilcoyne Committee
|
House, 12th Worcester
|
$200.00
|
| 02/06/2024 | Joseph A. Boncore |
Thomas Stanley Committee
|
House, 9th Middlesex
|
$200.00
|
| 02/15/2024 | Joseph A. Boncore |
Michael Kushmerek Committee
|
House, 3rd Worcester
|
$200.00
|
| 02/29/2024 | Joseph A. Boncore |
Mark James Cusack Committee
|
House, 5th Norfolk
|
$200.00
|
| 03/25/2024 | Joseph A. Boncore |
Daniel Joseph Ryan Committee
|
House, 2nd Suffolk
|
$200.00
|
| 03/27/2024 | Joseph A. Boncore |
Christopher Worrell Committee
|
City Councilor, Boston
|
$200.00
|
| 04/02/2024 | Joseph A. Boncore |
Barry Finegold Committee
|
Senate, 2nd Essex & Middlesex
|
$200.00
|
| 04/02/2024 | Joseph A. Boncore |
Marjorie Decker Committee
|
House, 25th Middlesex
|
$200.00
|
| 04/02/2024 | Joseph A. Boncore |
Jack Patrick Lewis Committee
|
House, 7th Middlesex
|
$200.00
|
| 04/03/2024 | Joseph A. Boncore |
Jim Arciero Committee
|
House, 2nd Middlesex
|
$200.00
|
| 04/09/2024 | Joseph A. Boncore |
Joan Meschino Committee
|
House, 3rd Plymouth
|
$200.00
|
| 04/09/2024 | Joseph A. Boncore |
Ruthzee Louijeune Committee
|
City Councilor, Boston
|
$200.00
|
| 04/09/2024 | Joseph A. Boncore |
Michael Day Committee
|
House, 31st Middlesex
|
$200.00
|
| 04/10/2024 | Joseph A. Boncore |
Joyce Craig Committee
|
Governor, New Hampshire
|
$200.00
|
| 04/18/2024 | Joseph A. Boncore |
Adrian Madaro Committee
|
House, 1st Suffolk
|
$200.00
|
| 04/25/2024 | Joseph A. Boncore |
Jessica Giannino Committee
|
House, 16th Suffolk
|
$200.00
|
| 05/07/2024 | Joseph A. Boncore |
Committee for a Democratic Senate
|
N/A
|
$200.00
|
| 05/07/2024 | Joseph A. Boncore |
Ann-Margaret Ferrante committee
|
House, 5th Essex
|
$200.00
|
| 05/09/2024 | Joseph A. Boncore |
Jeffrey Roy Committee
|
House, 10th Norfolk
|
$200.00
|
| 05/15/2024 | Joseph A. Boncore |
Brandy Fluker Oakley Committee
|
House, 12th Suffolk
|
$200.00
|
| 05/22/2024 | Joseph A. Boncore |
Adam Gomez Committee
|
Senate, Hampden
|
$200.00
|
| 05/23/2024 | Joseph A. Boncore |
Sean Reid Committee
|
House, 11th Essex
|
$200.00
|
| 05/29/2024 | Joseph A. Boncore |
Nicholas Collins Committee
|
Senate, 1st Suffolk
|
$200.00
|
| 06/17/2024 | Joseph A. Boncore |
Joseph McGonagle Committee
|
House, 28th Middlesex
|
$200.00
|
| 06/20/2024 | Joseph A. Boncore |
Danielle Gregoire Committee
|
House, 4th Middlesex
|
$200.00
|
| | | | Total contributions |
$5,200.00
|
|
|
Client:
Massachusetts Biotechnology Council, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
801
|
An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4566
|
An act relative to access to midwifery care & out of hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2834
|
Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
976
|
An Act requiring full health insurance coverage for individuals with vitiligo
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
656
|
An Act to reduce the cost of pharmacy benefits
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1356
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4620
|
An act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
943
|
An Act to reduce co-pays for people with chronic conditions
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1197
|
An Act to provide rapid whole genome sequencing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
227
|
An Act establishing the Massachusetts Information Privacy and Security Act
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4459
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2484
|
An act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1180
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4109
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
767
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4138
|
Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
4
|
Senate Ways and Means Buget
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1206
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
616
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1181
|
An Act relative to transparency in the workplace
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4600
|
House Ways and Means Budget
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
850
|
An Act concerning the use of animals in product testing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4100
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
An Act relative to salary range transparency
|
|
Senate Bill
|
753
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4109
|
An act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4804
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
944
|
An Act reining in premiums through stronger rate review
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
799
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4486
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2800
|
Senate Budget
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
959
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1208
|
An Act establishing a state-wide drug repository program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
630
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1191
|
An Act relative to pay range disclosure
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4601
|
House Budget
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1055
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1247
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
714
|
An Act relative to pharmaceutical gag clauses
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1418
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4653
|
An act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1150
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3587
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
750
|
An Act relative to primary care for you
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2209
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4789
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1369
|
An Act to establish a pilot program for specialty pharmacy in urology
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4632
|
An Act establishing the Massachusetts Data Privacy Act
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1056
|
An Act establishing a commission to study maximum allowable costs lists
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1250
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
715
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1425
|
An Act relative to pharmacists as healthcare providers
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4707
|
Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2163
|
An Act relative to postpartum depression screenings
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1862
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4722
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1131
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
744
|
An Act establishing medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
2
|
Governor's Budget
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4726
|
Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1016
|
An Act to enact pharmacy benefit manager duties
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1239
|
An Act establishing Medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1375
|
An Act relative to postpartum depression screening
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4643
|
An act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1147
|
An Act ensuring access to specialty medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2249
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4733
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Client:
Pharmaceutical Research and Manufacturers of America Corporation
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Office of the Governor
|
Prescription drug pricing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Center for Health Information and Analysis (CHIA)
|
Prescription drug pricing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1016
|
An Act to enact pharmacy benefit manager duties
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
959
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Client:
Flatiron Energy Development LLC
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
2838
|
An Act upgrading the grid and protecting ratepayers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2531
|
An Act advancing grid enhancement technologies
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2829
|
An Act upgrading the grid and protecting ratepayers
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4222
|
An Act advancing grid enhancement technology
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3992
|
An Act to expand customer access to a modern grid
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2531
|
An Act advancing grid enhancement technologies
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3204
|
An Act establishing off-peak charging rebates
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4503
|
An Act relative to clean energy generation
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3166
|
An Act increasing opportunities for clean peak energy storage
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2140
|
An Act establishing off-peak charging rebates
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3216
|
An Act relative to clean energy generation
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Client:
SUN Initiative Financing LLC
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
1404
|
An Act relative to acute hospital governance
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1104
|
An Act relative to mortgage review boards and a small business loan review board within the Division of Banks
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Client:
Camp Harbor View Foundation, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
4
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Other
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2800
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4600
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Client:
Keolis Commuter Services, LLC
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
3366
|
An Act electrifying regional transit authorities
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Office of the Governor
|
Matters concerning commuter rail service in the Commonwealth. Expanded service, electrification of commuter rail and Battery Electric Mulitple unit trains /electric trains.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3908
|
An Act improving rail service on the Fairmount commuter rail line
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3901
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2271
|
An Act improving rail service on the Fairmount commuter rail line
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2402
|
An Act improving rail service on the Fairmount commuter rail line
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3315
|
An Act improving rail service on the Fairmount commuter rail line
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2217
|
An Act relative to setting deadlines to electrify the MBTA commuter rail
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3392
|
An Act relative to setting deadlines to electrify the commuter rail
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2400
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Client:
Friends of the Children - Boston
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
4
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Other
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Attorney General's Office (AGO)
|
Discussion regarding mentorship programing and grant making authority of Attorney Genreal's Office
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2800
|
An Act making appropriations for fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent im
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Client:
Neighborhood of Affordable Housing, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
4726
|
Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2834
|
Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services)
|
Discussions with Secretariat of Housing and Livable Communities regarding affordable housing in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Client:
Alexion Pharmaceuticals, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services)
|
Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
976
|
An Act requiring full health insurance coverage for individuals with vitiligo
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1055
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1131
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Office of the Governor
|
Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
943
|
An Act to reduce co-pays for people with chronic conditions
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
944
|
An Act reining in premiums through stronger rate review
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
850
|
An Act concerning the use of animals in product testing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
656
|
An Act to reduce the cost of pharmacy benefits
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1356
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1369
|
An Act to establish a pilot program for specialty pharmacy in urology
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2163
|
An Act relative to postpartum depression screenings
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1862
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
799
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
959
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1208
|
An Act establishing a state-wide drug repository program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
630
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1191
|
An Act relative to pay range disclosure
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1016
|
An Act to enact pharmacy benefit manager duties
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1239
|
An Act establishing Medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1375
|
An Act relative to postpartum depression screening
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1056
|
An Act establishing a commission to study maximum allowable costs lists
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1250
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
715
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1425
|
An Act relative to pharmacists as healthcare providers
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1147
|
An Act ensuring access to specialty medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2249
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2499
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1150
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3587
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
750
|
An Act relative to primary care for you
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4100
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
753
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1247
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
714
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1418
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
744
|
An Act establishing medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2492
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1197
|
An Act to provide rapid whole genome sequencing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
227
|
An Act establishing the Massachusetts Information Privacy and Security Act
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1180
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4109
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
767
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
801
|
An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1206
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
616
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1181
|
An Act relative to transparency in the workplace
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 02/08/2024 | Shannon Moore |
Maura Healey Committee
|
Governor
|
$200.00
|
| 02/15/2024 | Shannon Moore |
Steven Owens Committee
|
House, 29th Middlesex
|
$100.00
|
| 03/20/2024 | Shannon Moore |
John Moran Committee
|
House, 9th Suffolk
|
$100.00
|
| 03/28/2024 | Shannon Moore |
Alice Hanlon Peisch Committee
|
House, 14th Norfolk
|
$200.00
|
| 04/02/2024 | Shannon Moore |
Jack Patrick Lewis Committee
|
House, 7th Middlesex
|
$150.00
|
| 04/02/2024 | Shannon Moore |
Marjorie Decker Committee
|
House, 25th Middlesex
|
$100.00
|
| 04/02/2024 | Shannon Moore |
Barry Finegold Committee
|
Senate, 2nd Essex & Middlesex
|
$200.00
|
| 04/03/2024 | Shannon Moore |
Jim Arciero Committee
|
House, 2nd Middlesex
|
$100.00
|
| 04/03/2024 | Shannon Moore |
Michael Day Committee
|
House, 31st Middlesex
|
$100.00
|
| 04/24/2024 | Shannon Moore |
Andy Vargas Committee
|
House, 3rd Essex
|
$100.00
|
| 04/29/2024 | Shannon Moore |
Michael Rodrigues Committee
|
Senate, 1st Bristol & Plymouth
|
$200.00
|
| 05/09/2024 | Shannon Moore |
Jeffrey Roy Committee
|
House, 10th Norfolk
|
$100.00
|
| 05/09/2024 | Shannon Moore |
Adrian Madaro Committee
|
House, 10th Norfolk
|
$100.00
|
| 05/14/2024 | Shannon Moore |
Aaron Michlewitz Committee
|
House, 3rd Suffolk
|
$100.00
|
| 05/21/2024 | Shannon Moore |
Michael Kushmerek Committee
|
House, 3rd Worcester
|
$100.00
|
| 06/24/2024 | Shannon Moore |
John Lawn Committee
|
House, 10th Middlesex
|
$200.00
|
| | | | Total contributions |
$2,150.00
|
|
|
|
|
|